Market Cap (In EUR)
2.18 Billion
Revenue (In EUR)
-199.56 Million
Net Income (In EUR)
-206.6 Million
Avg. Volume
17.97 Thousand
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 37.75-52.6
- PE
- -
- EPS
- -
- Beta Value
- 0.826
- ISIN
- CH0038389992
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Employee Count
- -
- Website
- https://www.bbbiotech.ch/en/bb-biotech/
- Ipo Date
- 2020-06-29
- Details
- BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
More Stocks
-
ALGEVGévelot SA
ALGEV
-
2871Nichirei Corporation
2871
-
ENR
-
FTN
-
306200SeAH Steel Corporation
306200
-
002232
-
1723
-
COEP